These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 11397874

  • 1. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: alterations in cortisol pharmacokinetics at puberty.
    Charmandari E, Hindmarsh PC, Johnston A, Brook CG.
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2701-8. PubMed ID: 11397874
    [Abstract] [Full Text] [Related]

  • 2. Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory?
    Charmandari E, Matthews DR, Johnston A, Brook CG, Hindmarsh PC.
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4679-85. PubMed ID: 11600525
    [Abstract] [Full Text] [Related]

  • 3. Flutamide decreases cortisol clearance in patients with congenital adrenal hyperplasia.
    Charmandari E, Calis KA, Keil MF, Mohassel MR, Remaley A, Merke DP.
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3197-200. PubMed ID: 12107224
    [Abstract] [Full Text] [Related]

  • 4. Cortisol and 17-hydroxyprogesterone kinetics in saliva after oral administration of hydrocortisone in children and young adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Gröschl M, Rauh M, Dörr HG.
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1200-4. PubMed ID: 11889188
    [Abstract] [Full Text] [Related]

  • 5. Oral hydrocortisone administration in children with classic 21-hydroxylase deficiency leads to more synchronous joint GH and cortisol secretion.
    Charmandari E, Pincus SM, Matthews DR, Johnston A, Brook CG, Hindmarsh PC.
    J Clin Endocrinol Metab; 2002 May; 87(5):2238-44. PubMed ID: 11994370
    [Abstract] [Full Text] [Related]

  • 6. Classic congenital adrenal hyperplasia and puberty.
    Charmandari E, Brook CG, Hindmarsh PC.
    Eur J Endocrinol; 2004 Nov; 151 Suppl 3():U77-82. PubMed ID: 15554890
    [Abstract] [Full Text] [Related]

  • 7. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Völkl TM, Simm D, Beier C, Dörr HG.
    Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
    [Abstract] [Full Text] [Related]

  • 8. Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Charmandari E, Johnston A, Brook CG, Hindmarsh PC.
    J Endocrinol; 2001 Apr; 169(1):65-70. PubMed ID: 11250647
    [Abstract] [Full Text] [Related]

  • 9. Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty.
    Bonfig W, Bechtold S, Schmidt H, Knorr D, Schwarz HP.
    J Clin Endocrinol Metab; 2007 May; 92(5):1635-9. PubMed ID: 17299071
    [Abstract] [Full Text] [Related]

  • 10. Bone mineral density and body composition in congenital adrenal hyperplasia.
    Cameron FJ, Kaymakci B, Byrt EA, Ebeling PR, Warne GL, Wark JD.
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2238-43. PubMed ID: 7608286
    [Abstract] [Full Text] [Related]

  • 11. Management of altered hydrocortisone pharmacokinetics in a boy with congenital adrenal hyperplasia using a continuous subcutaneous hydrocortisone infusion.
    Bryan SM, Honour JW, Hindmarsh PC.
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3477-80. PubMed ID: 19567522
    [Abstract] [Full Text] [Related]

  • 12. Effect of carbenoxolone on the plasma renin activity and hypothalamic-pituitary-adrenal axis in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Irony I, Cutler GB.
    Clin Endocrinol (Oxf); 1999 Sep; 51(3):285-91. PubMed ID: 10469007
    [Abstract] [Full Text] [Related]

  • 13. Hydrocortisone dosing during puberty in patients with classical congenital adrenal hyperplasia: an evidence-based recommendation.
    Bonfig W, Pozza SB, Schmidt H, Pagel P, Knorr D, Schwarz HP.
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3882-8. PubMed ID: 19622620
    [Abstract] [Full Text] [Related]

  • 14. [Puberty and growth development in patients with a 21-hydroxylase defect].
    Börger D, Willig RP.
    Monatsschr Kinderheilkd; 1985 Nov; 133(11):828-33. PubMed ID: 2934617
    [Abstract] [Full Text] [Related]

  • 15. Normal bone mineral density and lean body mass, but increased fat mass, in young adult patients with congenital adrenal hyperplasia.
    Stikkelbroeck NM, Oyen WJ, van der Wilt GJ, Hermus AR, Otten BJ.
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1036-42. PubMed ID: 12629082
    [Abstract] [Full Text] [Related]

  • 16. Variation in absorption and half-life of hydrocortisone influence plasma cortisol concentrations.
    Hindmarsh PC, Charmandari E.
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):557-61. PubMed ID: 25369980
    [Abstract] [Full Text] [Related]

  • 17. Treatment with flutamide decreases cortisol clearance: implications for therapy in congenital adrenal hyperplasia.
    Charmandari E, Johnston A, Honour JW, Brook CG, Hindmarsh PC.
    J Pediatr Endocrinol Metab; 2002 Apr; 15(4):435-9. PubMed ID: 12008691
    [Abstract] [Full Text] [Related]

  • 18. Sexual dimorphism in the synchrony of joint growth hormone and cortisol dynamics in children with classic 21-hydroxylase deficiency.
    Charmandari E, Pincus SM, Matthews DR, Johnston A, Brook CG, Hindmarsh PC.
    J Pediatr Endocrinol Metab; 2003 Apr; 16(8):1119-30. PubMed ID: 14594172
    [Abstract] [Full Text] [Related]

  • 19. The effects of glucocorticoid replacement therapy on growth, bone mineral density, and bone turnover markers in children with congenital adrenal hyperplasia.
    Girgis R, Winter JS.
    J Clin Endocrinol Metab; 1997 Dec; 82(12):3926-9. PubMed ID: 9398689
    [Abstract] [Full Text] [Related]

  • 20. Gender related differences in glucocorticoid therapy and growth outcomes among pubertal children with 21-hydroxylase deficiency congenital adrenal hyperplasia (CAH).
    Deslauriers JR, Lenz AM, Root AW, Diamond FB, Bercu BB.
    J Pediatr Endocrinol Metab; 2012 Dec; 25(9-10):977-81. PubMed ID: 23426829
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.